These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21173506)

  • 1. Transmural dispersion of repolarization and drug-induced Torsade de Pointes. -A 3-D simulation study-.
    Furukawa T
    Circ J; 2011; 75(1):49-50. PubMed ID: 21173506
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmural dispersion of repolarization determines scroll wave behavior during ventricular tachyarrhythmias.
    Haraguchi R; Ashihara T; Namba T; Tsumoto K; Murakami S; Kurachi Y; Ikeda T; Nakazawa K
    Circ J; 2011; 75(1):80-8. PubMed ID: 21099125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing.
    Fish JM; Di Diego JM; Nesterenko V; Antzelevitch C
    Circulation; 2004 May; 109(17):2136-42. PubMed ID: 15078801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
    Lu HR; Hermans AN; Gallacher DJ
    Br J Pharmacol; 2012 Jun; 166(4):1490-502. PubMed ID: 22300168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?
    Medina-Ravell VA; Lankipalli RS; Yan GX; Antzelevitch C; Medina-Malpica NA; Medina-Malpica OA; Droogan C; Kowey PR
    Circulation; 2003 Feb; 107(5):740-6. PubMed ID: 12578878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes.
    Antzelevitch C
    Heart Rhythm; 2005 Nov; 2(2 Suppl):S9-15. PubMed ID: 16253930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of factors affecting the progression and termination of drug induced Torsade de pointes in two dimensional cardiac tissue.
    Kirthi Priya P; Reddy MR
    J Electrocardiol; 2017; 50(3):332-341. PubMed ID: 28202194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of early afterdepolarizations on reentry in cardiac tissue: a simulation study.
    Huffaker RB; Weiss JN; Kogan B
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3089-102. PubMed ID: 17307992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
    Frommeyer G; von der Ahe H; Brücher B; Dechering DG; Lange PS; Reinke F; Wasmer K; Köbe J; Pott C; Mönnig G; Eckardt L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1073-80. PubMed ID: 27405774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oscillations of cardiac wave length and proarrhythmia.
    Hondeghem LM; Dumotier B; Traebert M
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):367-76. PubMed ID: 20803191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a typical I(Kr) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes.
    Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 2002 Apr; 88(4):414-21. PubMed ID: 12046984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.
    Antzelevitch C
    Europace; 2007 Sep; 9 Suppl 4(Suppl 4):iv4-15. PubMed ID: 17766323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bi-stable wave propagation and early afterdepolarization-mediated cardiac arrhythmias.
    Chang MG; Sato D; de Lange E; Lee JH; Karagueuzian HS; Garfinkel A; Weiss JN; Qu Z
    Heart Rhythm; 2012 Jan; 9(1):115-22. PubMed ID: 21855520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects of bepridil on ventricular repolarization in humans. Inhomogeneous prolongation of the action potential duration vs flattening of its restitution kinetics.
    Osaka T; Yokoyama E; Kushiyama Y; Hasebe H; Kuroda Y; Suzuki T; Kodama I
    Circ J; 2009 Sep; 73(9):1612-8. PubMed ID: 19609043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall.
    Yan GX; Wu Y; Liu T; Wang J; Marinchak RA; Kowey PR
    Circulation; 2001 Jun; 103(23):2851-6. PubMed ID: 11401944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation.
    Di Diego JM; Belardinelli L; Antzelevitch C
    Circulation; 2003 Aug; 108(8):1027-33. PubMed ID: 12912819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.